Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 258
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Why Don’t Magic Mushroom Spores Contain Psilocybin?
Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain
Is Nitrous Oxide a Psychedelic Drug?
Keeping Participants Safe in Psychedelic Research
Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at...
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD...
atai Launches Revixia Life Sciences to Develop Salvinorin A for a...
Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under...
Psychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin...
Cybin Announces Additional Adelia Milestone Achievements
Load more